1. Home
  2. ESPR vs ZSQR Comparison

ESPR vs ZSQR Comparison

Compare ESPR & ZSQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$3.19

Market Cap

816.9M

Sector

Health Care

ML Signal

HOLD

Logo Z Squared Inc. Common Stock

ZSQR

Z Squared Inc. Common Stock

N/A

Current Price

$5.12

Market Cap

697.4M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
ESPR
ZSQR
Founded
2008
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
816.9M
697.4M
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
ESPR
ZSQR
Price
$3.19
$5.12
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$8.75
N/A
AVG Volume (30 Days)
16.8M
893.8K
Earning Date
05-07-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
60.71
N/A
EPS
N/A
N/A
Revenue
$403,135,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$12.81
N/A
P/E Ratio
N/A
N/A
Revenue Growth
21.31
N/A
52 Week Low
$1.11
$5.28
52 Week High
$4.18
$16.62

Technical Indicators

Market Signals
Indicator
ESPR
ZSQR
Relative Strength Index (RSI) 67.43 20.78
Support Level $3.16 N/A
Resistance Level $3.26 $8.79
Average True Range (ATR) 0.02 1.67
MACD -0.01 -0.58
Stochastic Oscillator 78.57 7.70

Price Performance

Historical Comparison
ESPR
ZSQR

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a commercial-stage biopharmaceutical company currently focused on bringing new medicines to patients that address unmet medical needs. It has developed and is commercializing U.S. Food and Drug Administration, or FDA, approved oral, once-daily, non-statin medicines for patients who are at risk for cardiovascular disease (or CVD and are struggling with elevated low-density lipoprotein cholesterol, or LDL-C. The Company views its operations and manages its business in one operating segment, which is the business of researching, developing, and commercializing therapies for the treatment of patients with elevated LDL-C. The company depends almost entirely on the success of two products, the bempedoic acid tablet and the bempedoic acid/ezetimibe combination tablet.

About ZSQR Z Squared Inc. Common Stock

Z Squared Inc is a computing infrastructure company operating computing equipment and expanding into AI infrastructure. The Company's idea is to build on three principles: guide with power by acquiring operating sites where power is already flowing; build for AI workloads by converting that capacity into AI-ready colocation where the customer brings the compute and runs what it needs; and scale with discipline by deploying conversion capital site by site, against signed contracts and operational readiness.

Share on Social Networks: